• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Phase 2 Trial

Recent news which mentions Phase 2 Trial

< Previous 1 2 3 4 5 6 7 8 9 Next >
Why Are Cortexyme Shares Falling Today?
November 11, 2021
Tickers CRTX
Tags Phase 3 Trial Market News Alzheimer's disease
From Benzinga
Freeline Therapeutics Touts Encouraging Data From Fabry Disease Program
November 10, 2021
Tickers FRLN
Tags Penny Stocks FRLN News
From Benzinga
Finch Therapeutics' C. Difficile Infection Candidate Meets Primary Goal In Mid-Stage Study
November 10, 2021
Tickers FNCH
Tags Market News Trading Ideas Briefs
From Benzinga
GeoVax Labs In-Licenses Development Rights To Multi-Antigenic COVID-19 Vaccine Candidate
November 10, 2021
Tickers BNTX GOVX PFE
Tags News General Penny Stocks
From Benzinga
Immutep's Lead Candidate Data In Breast Cancer Trial Fails To Lift The Stock
November 09, 2021
Tickers IMMP
Tags News breast cancer IMMP
From Benzinga
Compass Pathways' Psilocybin Therapy Shows Mixed Results From Depression Trial
November 09, 2021
Tickers CMPS
Tags Market News CMPS Biotech
From Benzinga
Seelos Therapeutics To Test Trehalose In Patients With Rare Movement Control Disorder
November 08, 2021
Tickers SEEL
Tags Phase 2 Trial Benzinga Biotech
From Benzinga
MorphoSys Presents Early Felzartamab Data From Autoimmune Kidney Disease Trial
November 05, 2021
Tickers IMAB MOR
Tags Kidney Diseases General News
From Benzinga
Why Did Calithera Shares Dropped To 52-Week Low In Premarket Friday?
November 05, 2021
Tickers CALA
Tags Market News Phase 2 Trial Biotech
From Benzinga
Why Did Sangamo Stock Jump 20% Today?
November 04, 2021
Tickers SGMO
Tags SGMO Market News Phase 1 Trial
From Benzinga
Novartis' Iptacopan Meets Primary Endpoint Goal In Rare Kidney Disease Trial
November 04, 2021
Tickers NVS
Tags Market News Phase 2 Trial Biotech
From Benzinga
Achieve Life Sciences To Start Cytisinicline's Trial For Nicotine E-cigarette Cessation
November 02, 2021
Tickers ACHV
Tags Phase 2 Trial Benzinga Movers
From Benzinga
Aldeyra's Dry Eye Disease Trial Meets Primary Endpoint, But Did Not Reach Statistical Significance
November 02, 2021
Tickers ALDX
Tags General News Benzinga
From Benzinga
Galecto To Test GB1211 Combined with Roche's Tecentriq In First Line Lung Cancer Setting
November 02, 2021
Tickers GLTO RHHBF RHHBY RHHVF
Tags Phase 2 Trial Briefs Biotech
From Benzinga
Metacrine Posts Data From MET409 Combination Trial In Diabetes, NASH Patients
November 02, 2021
Tickers LLY MTCR
Tags General News Non Alcoholic steatohepatitis
From Benzinga
Cocrystal Pharma Files To Start Human Trial For Protease Inhibitor In COVID-19
November 01, 2021
Tickers COCP
Tags Biotech Briefs Trading Ideas
From Benzinga
ATAI Life's Schizophrenia Candidate Shows Promising Action In Mid-Stage Study
November 01, 2021
Tickers ATAI
Tags News General Schizophrenia
From Benzinga
AstraZeneca's Medimmune Terminates DNA Cancer Vaccine Program With Inovio
November 01, 2021
Tickers AZN AZNCF INO
Tags General News Benzinga
From Benzinga
ARCA Biopharma Stock Gains As Safety Committee Recommends COVID-19 Trial To Continue Unchanged
October 29, 2021
Tickers ABIO
Tags Movers Benzinga Health Care
From Benzinga
Inventiva Plans To Start Lanifibranor Combo Study In NASH, Diabetes In 2022
October 28, 2021
Tickers IVA LLY
Tags Phase 2 Trial IVA Type 2 Diabetes
From Benzinga
Why Did BioVie Shares Jump 21% Today?
October 26, 2021
Tickers BIVI
Tags Briefs Health Care Biotech
From Benzinga
4D Molecular's Fabry Disease Candidate Shows Early Proof-Of-Concept
October 26, 2021
Tickers FDMT
Tags Health Care Biotech Fabry disease
From Benzinga
Ventyx Jumps Over 20% Today After NASDAQ Debut
October 21, 2021
Tickers BMY FPX IPO IPOS
Tags ulcerative colitis Market News Phase 2 Trial
From Benzinga
PDS Biotech Pauses Recruitment In PDS0101 Combo Cancer Trial
October 21, 2021
Tickers MRK PDSB
Tags Market News cancer Phase 2 Trial
From Benzinga
Stealth Bio Stock Falls On FDA Refusal to File Letter For Barth Syndrome Candidate
October 20, 2021
Tickers MITO
Tags Market News Phase 2 Trial Briefs
From Benzinga
Rocket Pharma Posts Interim Data From Immunodeficiency Disorder Gene Therapy Trial
October 20, 2021
Tickers RCKT
Tags Phase 2 Trial Briefs Biotech
From Benzinga
ImmunityBio Meets Endpoint In Second Indication Cohort In Bladder Cancer Trial
October 19, 2021
Tickers IBRX
Tags Phase 2 Trial Benzinga IBRX
From Benzinga
Edesa Biotech Shares Gain As Its COVID-19 Antibody Shows Favorable Mortality Reductions
October 19, 2021
Tickers EDSA
Tags Market News Phase 3 Trial Briefs
From Benzinga
InflaRx Secures €44M Grant From German Govt To Advance Its COVID-19 Trial
October 19, 2021
Tickers IFRX
Tags Long Ideas Penny Stocks Government
From Benzinga
Why Are Atea Pharmaceuticals Shares Plunging Today?
October 19, 2021
Tickers AVIR RHHBF RHHBY RHHVF
Tags Market News Trading Ideas RHHBY
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap